Junhua Xie

Prof. Junhua Xie

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2022 in Trends in Biotechnology
Verified
Journal Article
Closed access
Junhua XieJunhua Xie
Junhua Xie
QLQiqiong Li
Qiqiong Li
FHFreddy Haesebrouck
Freddy Haesebrouck
LHLien Van Hoecke
Lien Van Hoecke
Roosmarijn VandenbrouckeRoosmarijn Vandenbroucke
Roosmarijn Vandenbroucke

16 June 2023 in Trends in Microbiology
Verified
Journal Article
Closed access
Junhua XieJunhua Xie
Junhua Xie
FHFreddy Haesebrouck
Freddy Haesebrouck
LHLien Van Hoecke
Lien Van Hoecke
Roosmarijn VandenbrouckeRoosmarijn Vandenbroucke
Roosmarijn Vandenbroucke

15 February 2023 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
Junhua XieJunhua Xie
Junhua Xie
LCLien Cools
Lien Cools
GIGriet Van Imschoot
Griet Van Imschoot
EWElien Van Wonterghem
Elien Van Wonterghem
MPMarie J. Pauwels
Marie J. Pauwels
Roosmarijn VandenbrouckeRoosmarijn Vandenbroucke
Roosmarijn Vandenbroucke
The gut microbiota represents a diverse and dynamic population of microorganisms that can influence the health of the host. Increasing evidence supports the role of the gut microbiota as a key player in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD). Unfortunately, the mechanisms behind the interplay between gut pathogens and AD are still elusive. It is known that bacteria‐derived outer membrane vesicles (OMVs) act as natural carriers of virulence factors that are central players in the pathogenesis of the bacteria. Helicobacter pylori (H. pylori) is a common gastric pathogen and H. pylori infection has been associated with an increased risk to develop AD. Here, we are the first to shed light on the role of OMVs derived from H. pylori on the brain in healthy conditions and on disease pathology in the case of AD. Our results reveal that H. pylori OMVs can cross the biological barriers, eventually reaching the brain. Once in the brain, these OMVs are taken up by astrocytes, which induce activation of glial cells and neuronal dysfunction, ultimately leading to exacerbated amyloid‐β pathology and cognitive decline. Mechanistically, we identified a critical role for the complement component 3 (C3)‐C3a receptor (C3aR) signalling in mediating the interaction between astrocytes, microglia and neurons upon the presence of gut H. pylori OMVs. Taken together, our study reveals that H. pylori has a detrimental effect on brain functionality and accelerates AD development via OMVs and C3‐C3aR signalling.

10 February 2025 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
XNXinke Nie
Xinke Nie
QLQiqiong Li
Qiqiong Li
HJHaihua Ji
Haihua Ji
SZShanshan Zhang
Shanshan Zhang
YWYuchen Wang
Yuchen Wang
SNShao-Ping Nie
Shao-Ping Nie
Recent studies have shown that intestinal commensal bacteria-derived vesicles may have potential effects in alleviating ulcerative colitis (UC). Although Bifidobacterium longum is widely used to prevent colitis, the potential role of B. longum-derived extracellular vesicles has yet to be explored. Here, we extracted B. longum NSP001-derived extracellular vesicles (NEVs) and investigated the regulatory roles of NEVs in colitis. Our results demonstrated that NEVs alleviate UC by improving intestinal barrier, modulating immune cell differentiation, and promoting the production of SCFAs. NEVs’ improvement of inflammation in pseudo-germ-free mice implies that the anti-inflammatory effect of NEVs does not exclusively depend on the regulation of gut microbiota. In conclusion, we suggest that B. longum NSP001 improves UC through the secretion of NEVs. In addition, the study emphasizes the critical role of NEVs in maintaining host immune homeostasis via suppressing STAT3 pathway, thereby highlighting their potential as a novel postbiotic to alleviate UC.

23 August 2024 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
XCXinyang Chen
Xinyang Chen
QLQiqiong Li
Qiqiong Li
Junhua XieJunhua Xie
Junhua Xie
SNShaoping Nie
Shaoping Nie

6 January 2026 in Gut Microbes
Verified
Journal Article
Open access
XCXinyang Chen
Xinyang Chen
QLQiqiong Li
Qiqiong Li
WZWanyu Zhang
Wanyu Zhang
YXYushan Xu
Yushan Xu
XNXinke Nie
Xinke Nie
SNShao-Ping Nie
Shao-Ping Nie
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with systemic manifestations, including cognitive impairment linked to gut‒brain axis dysregulation. While probiotic therapies show promise, their mechanisms in mitigating neuropsychiatric comorbidities remain unclear. Here, we investigated the therapeutic potential of Akkermansia muciniphila-derived extracellular vesicles (AmEVs) in a murine model of dextran sulfate sodium (DSS)-induced colitis and associated cognitive deficits. AmEVs administration significantly alleviated colitis severity, as evidenced by improved weight retention, reduced disease activity index scores, and colon length restoration. Concurrently, AmEVs reversed colitis-driven cognitive impairments, restoring Y-maze and novel object recognition performance to baseline levels. Mechanistically, AmEVs repaired intestinal and blood‒brain barrier integrity by upregulating tight junction proteins, suppressed neuroinflammation via reduced hippocampal pro-inflammatory cytokines, and inhibited microglial/astrocyte activation. Gut microbiota analysis revealed that AmEVs-mediated enrichment of beneficial Bifidobacterium and suppression of pathogenic Bacteroides and Mucispirillum, alongside restored short-chain fatty acid (SCFA) production. Crucially, AmEVs bidirectionally regulated tryptophan metabolism, reducing colonic serotonin (5-HT) overproduction while restoring hippocampal 5-HT levels and 5-HT1A receptor expression. This was accompanied by enhanced synaptic plasticity and BDNF upregulation in the hippocampus. Proteomic and biodistribution studies confirmed AmEVs' delivery of metabolic regulators to hippocampal neurons, including the key protein Amuc_1100,directly enhancing 5-HT production in vitro. Our findings establish AmEVs as a multifaceted therapeutic agent that concurrently resolves gut inflammation and cognitive deficits via gut-brain axis modulation, offering novel strategies for IBD-related neuropsychiatric comorbidities. Further research is warranted to validate critical vesicular components and optimize clinical translation.